H. Lee Moffitt Cancer Center & Research Institute
Last Modified: February 25, 2007
Conference Dates: March 10-11, 2007
Conference Location: Sheraton Sand Key Resort, Clearwater Beach, Florida
Sponsoring Group: H. Lee Moffitt Cancer Center & Research Institute & USF Health
Conference Web Page URL: www.moffitt.org/continuinged/gionc
Topics Covered: This course will review new advances in the treatment, early detection and prevention of esophageal, stomach, colorectal, pancreas, and neuroendocrine cancers. It also includes an update on translational science related to these cancers. The program focuses on clinical management and issues facing medical oncologists, radiation oncologists, surgical oncologists, nurses, pharmacists, and endoscopists. The format will be comprised of four brief sessions, and each session will integrate case presentations by an interdisciplinary team of physicians highlighting diagnostic and treatment dilemmas faced in daily practice.
*Evaluate the latest advances in pathology, diagnositc and prognostic staging and interventions for colorectal, pancreatic and esophageal cancers. *Examine strategies to deliver personalized therapy and quality cancer care of patients with GI tumors. *Review the latest translational advances in GI oncology.
Who Should Attend: Medical Oncologists, surgical oncologists, radiation oncologists, physician assistants, nurse practitioners, nurses, endoscopists and pharmacists who are involved in treating gastrointestinal oncology patients. Space is available for residents, fellows, and medical students.
Registration Information: To register online. If you have any questions, please contact Melissa Pearson at 813-745-1741 or e-mail Melissa.Pearson@moffitt.org.
Conference Fees: $145 Physicians $85 PA, ARNP, RN, Pharmacist and Other Healthcare Professionals
Continuing Education: Yes
Nov 14, 2014 - In a study of 241 ,597 women who had breast conservation surgery for breast cancer, 23.6 percent needed a second operation. The report was published online Nov. 12 in JAMA Surgery.